Transcend is a medical device company focused on the development of minimally invasive therapies for the treatment of glaucoma. Transcend’s lead program is the CyPass Micro-Stent, a tiny implant placed in the eye through a minimally invasive surgical procedure intended to be an earlier intervention than conventional surgical treatments and to reduce or eliminate the need for glaucoma medications while providing continuous control of intraocular pressure.
- Sector: Healthcare
- Status: Private
- Geographic Market: U.S.
- Investment Year: 2011
- Board Representation: Abhijeet Lele
- Investment Team: Yuriy Prilutskiy
Visit the company’s website.